InvestorsHub Logo

Dead On Arrival

04/29/24 12:57 PM

#111479 RE: monocle #111477

I just checked on GX's last merger deal with Celularity. The price has been decimated down to 3 cents with a 1:10 r/s already done. The shareholders were wiped out. Niocorp has the same look as of today although they do have physical assets compared to a biotech. The person responsible for advising this merger should have been fired. GX is a virus that infects every company they come into contact with. Stock price down 77.5% as of this post. Absolute ****ing travesty that was heaped on retail shareholders. No institutional support whatsoever. Even if the stock rallies, some of the first retail wave is long gone.

Management should be ashamed of themselves for taking raises and bonuses while the price is in tatters.